chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: "tired feeling"; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE ("tired feeling") in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE ("tired feeling"). At the time of the report, FATIGUE ("tired feeling") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment medications was not given.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Nausea
Clinical narrative: episodes of nausea; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and NAUSEA (episodes of nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). In May 2021, the patient experienced NAUSEA (episodes of nausea). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) had resolved and NAUSEA (episodes of nausea) outcome was unknown.            No concomitant medications reported.  Treatment information not reported.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Pretty high fever. 102.2; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Pretty high fever. 102.2) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Pretty high fever. 102.2). At the time of the report, PYREXIA (Pretty high fever. 102.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102.2 (High) Pretty high fever. 102.2.         No concomitant medications were reported.  No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: heart rate increased; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart rate increased) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Overweight.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (heart rate increased). At the time of the report, HEART RATE INCREASED (heart rate increased) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Bump on the back, possible shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Bump on the back, possible shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Bump on the back, possible shingles). At the time of the report, HERPES ZOSTER (Bump on the back, possible shingles) outcome was unknown.            No treatment medication reported. No concomitant medication was reported. AE submitted via ChatBot.  Consent for follow up denied.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: i got my firs dose of de vaccine on april 14.. and didnt get the second; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (i got my firs dose of de vaccine on april 14.. and didnt get the second) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (i got my firs dose of de vaccine on april 14.. and didnt get the second). At the time of the report, PRODUCT DOSE OMISSION ISSUE (i got my firs dose of de vaccine on april 14. and didnt get the second) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details were provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Headache; Fever; Chills; body aches and her arm is sore; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (body aches and her arm is sore) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (body aches and her arm is sore). At the time of the report, HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (body aches and her arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment medication were given.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Chills, Vomiting
Clinical narrative: Really bad stomach ache; Really bad chills/Can't stop shivering; Some vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Really bad stomach ache), CHILLS (Really bad chills/Can't stop shivering) and VOMITING (Some vomiting) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by reporter.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Really bad stomach ache), CHILLS (Really bad chills/Can't stop shivering) and VOMITING (Some vomiting). At the time of the report, ABDOMINAL PAIN UPPER (Really bad stomach ache), CHILLS (Really bad chills/Can't stop shivering) and VOMITING (Some vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.5 (Inconclusive) 100.5.         No concomitant and treatment medications are provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up received on 23-Jun-2021, No new information. Patient Denied to Consent to Follow up.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Diarrhoea, Fatigue, Feeling abnormal, Myalgia
Clinical narrative: Suspected Covid-19; Feeling bad; Loss sense of smell.; Diarrhea; Muscle ache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Suspected Covid-19), FEELING ABNORMAL (Feeling bad), ANOSMIA (Loss sense of smell.), DIARRHOEA (Diarrhea) and MYALGIA (Muscle ache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus since 2010 and Cardiomyopathy since 2020. Concomitant products included METFORMIN HYDROCHLORIDE (METFORMIN XR), DULAGLUTIDE (TRULICITY), ROSUVASTATIN CALCIUM (CRESTOR), CARVEDILOL (COREG) and VALSARTAN (DIOVAN) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jun-2021, the patient experienced FEELING ABNORMAL (Feeling bad) and ANOSMIA (Loss sense of smell.). On 19-Jun-2021, the patient experienced SUSPECTED COVID-19 (Suspected Covid-19). On an unknown date, the patient experienced DIARRHOEA (Diarrhea), MYALGIA (Muscle ache) and FATIGUE (Fatigue). At the time of the report, SUSPECTED COVID-19 (Suspected Covid-19), FEELING ABNORMAL (Feeling bad), ANOSMIA (Loss sense of smell.), DIARRHOEA (Diarrhea), MYALGIA (Muscle ache) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jun-2021, SARS-CoV-2 test: positive (Positive) Positive (Rapid Molecular Nasal Swab).         After getting suspected for COVID-19 the patient was quarantined for 10 days.  Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant follow up, patient demographics, medical history, concomitant and treatment medications and new events were updated.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: Suspected Covid-19; Feeling bad; Loss sense of smell.; Diarrhea; Muscle ache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Suspected Covid-19), FEELING ABNORMAL (Feeling bad), ANOSMIA (Loss sense of smell.), DIARRHOEA (Diarrhea) and MYALGIA (Muscle ache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus since 2010 and Cardiomyopathy since 2020. Concomitant products included METFORMIN HYDROCHLORIDE (METFORMIN XR), DULAGLUTIDE (TRULICITY), ROSUVASTATIN CALCIUM (CRESTOR), CARVEDILOL (COREG) and VALSARTAN (DIOVAN) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jun-2021, the patient experienced FEELING ABNORMAL (Feeling bad) and ANOSMIA (Loss sense of smell.). On 19-Jun-2021, the patient experienced SUSPECTED COVID-19 (Suspected Covid-19). On an unknown date, the patient experienced DIARRHOEA (Diarrhea), MYALGIA (Muscle ache) and FATIGUE (Fatigue). At the time of the report, SUSPECTED COVID-19 (Suspected Covid-19), FEELING ABNORMAL (Feeling bad), ANOSMIA (Loss sense of smell.), DIARRHOEA (Diarrhea), MYALGIA (Muscle ache) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jun-2021, SARS-CoV-2 test: positive (Positive) Positive (Rapid Molecular Nasal Swab).         After getting suspected for COVID-19 the patient was quarantined for 10 days.  Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant follow up, patient demographics, medical history, concomitant and treatment medications and new events were updated.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: just had second shot and im Really sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (just had second shot and im Really sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (just had second shot and im Really sick). At the time of the report, ILLNESS (just had second shot and im Really sick) outcome was unknown.            Concomitant product usage were not provided. Treatment details were not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Myalgia, Pyrexia, Sluggishness
Clinical narrative: sluggish; Body aches; fatigue; fever; This spontaneous case was reported by a patient and describes the occurrence of SLUGGISHNESS (sluggish), MYALGIA (Body aches), FATIGUE (fatigue) and PYREXIA (fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy (Reaction- Sneezing, watery eyes.) since 1970, Allergic reaction to antibiotics (Rash) since 2005, Allergic reaction to bee sting (cellulitis) since August 2010, Allergy to molds (Reaction- Sneezing, watery eyes.) since 1970 and Seasonal allergy (Reaction- Sneezing, watery eyes.) since 1970. Concomitant products included MULTIVITAMIN [VITAMINS NOS], COLECALCIFEROL (D3), FISH OIL (OMEGA 3 [FISH OIL]), VACCINIUM MACROCARPON (CRANBERRY EXTRACT [VACCINIUM MACROCARPON]) and CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) for an unknown indication.   On 13-Mar-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021 at 11:15 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced SLUGGISHNESS (sluggish), MYALGIA (Body aches), FATIGUE (fatigue) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Apr-2021, MYALGIA (Body aches) and PYREXIA (fever) had resolved. On 12-Apr-2021, SLUGGISHNESS (sluggish) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 102 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-062244 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity
Clinical narrative: arm was sore; red and warm arm; red and warm arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), ERYTHEMA (red and warm arm) and FEELING HOT (red and warm arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A..A (illegible) and 031A21B) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included ATORVASTATIN, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ), DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ) and SEMAGLUTIDE (OZEMPIC) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), ERYTHEMA (red and warm arm) and FEELING HOT (red and warm arm). At the time of the report, PAIN IN EXTREMITY (arm was sore), ERYTHEMA (red and warm arm) and FEELING HOT (red and warm arm) outcome was unknown.            Treatment details were not provided.   This case was linked to MOD-2021-231407 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Muscle twitching
Clinical narrative: Muscle twitches; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE TWITCHING (Muscle twitches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced MUSCLE TWITCHING (Muscle twitches). At the time of the report, MUSCLE TWITCHING (Muscle twitches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: unknown (Inconclusive) Unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was reported. No treatment medication information was reported. Patient developed muscle twitches and other symptoms similar to Syndrome. They did blood work and treated her.   Reporter did not allow further contact
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Hyperhidrosis, Illness
Clinical narrative: felt like she had Covid again; sweating; chills; headache; been sick; felt all the aches; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (been sick), HYPERHIDROSIS (sweating), SYMPTOM RECURRENCE (felt like she had Covid again), MYALGIA (felt all the aches) and CHILLS (chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced ILLNESS (been sick) and MYALGIA (felt all the aches). On 22-Jun-2021, the patient experienced HYPERHIDROSIS (sweating), CHILLS (chills) and HEADACHE (headache). On 21-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SYMPTOM RECURRENCE (felt like she had Covid again). At the time of the report, ILLNESS (been sick), HYPERHIDROSIS (sweating), SYMPTOM RECURRENCE (felt like she had Covid again), MYALGIA (felt all the aches), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2021, Body temperature: 100.6f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant and  treatment medications were provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Symptom recurrence
Clinical narrative: felt like she had Covid again; sweating; chills; headache; been sick; felt all the aches; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (been sick), HYPERHIDROSIS (sweating), SYMPTOM RECURRENCE (felt like she had Covid again), MYALGIA (felt all the aches) and CHILLS (chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced ILLNESS (been sick) and MYALGIA (felt all the aches). On 22-Jun-2021, the patient experienced HYPERHIDROSIS (sweating), CHILLS (chills) and HEADACHE (headache). On 21-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SYMPTOM RECURRENCE (felt like she had Covid again). At the time of the report, ILLNESS (been sick), HYPERHIDROSIS (sweating), SYMPTOM RECURRENCE (felt like she had Covid again), MYALGIA (felt all the aches), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2021, Body temperature: 100.6f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant and  treatment medications were provided.
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Renal pain
Clinical narrative: cold sweats; kidney pain; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweats) and RENAL PAIN (kidney pain) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced COLD SWEAT (cold sweats) and RENAL PAIN (kidney pain). On 20-May-2021, COLD SWEAT (cold sweats) and RENAL PAIN (kidney pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD-2021-232335 (Patient Link).
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Feeling of body temperature change, Headache, Myalgia
Clinical narrative: Dry heaves; Kidney pain; Felt like he was burning up; Body shakes throughout the night that were cold and hot; Fatigue; Vomiting; Headache behind the eyes; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot) and MYALGIA (Body aches) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced MYALGIA (Body aches). On 17-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot), FATIGUE (Fatigue), VOMITING (Vomiting) and HEADACHE (Headache behind the eyes). On 20-May-2021, MYALGIA (Body aches) had resolved. On 18-Jun-2021, RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), VOMITING (Vomiting) and HEADACHE (Headache behind the eyes) had resolved. On 22-Jun-2021, FATIGUE (Fatigue) had resolved. At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot) had resolved.            No concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-232322 (Patient Link).
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Renal pain, Retching, Vomiting
Clinical narrative: Dry heaves; Kidney pain; Felt like he was burning up; Body shakes throughout the night that were cold and hot; Fatigue; Vomiting; Headache behind the eyes; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot) and MYALGIA (Body aches) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced MYALGIA (Body aches). On 17-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot), FATIGUE (Fatigue), VOMITING (Vomiting) and HEADACHE (Headache behind the eyes). On 20-May-2021, MYALGIA (Body aches) had resolved. On 18-Jun-2021, RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), VOMITING (Vomiting) and HEADACHE (Headache behind the eyes) had resolved. On 22-Jun-2021, FATIGUE (Fatigue) had resolved. At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot) had resolved.            No concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-232322 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Computerised tomogram, Deep vein thrombosis, Dyspnoea, Fibrin D dimer increased
Clinical narrative: I could not breathe/shortness of breath; I had palpitations; still have trouble going up the stairs; This spontaneous case was reported by a pharmacist and describes the occurrence of DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs). At the time of the report, DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Blood pressure increased: high (High) high. On 13-Feb-2021, Fibrin D dimer increased (Unknown-1.6): high (High) 1.6. On an unknown date, Computerised tomogram: inconclusive (Inconclusive) inconclusive. On an unknown date, Deep vein thrombosis: inconclusive (Inconclusive) inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant history was not reported .The treatment history was not provided. the lab tests conducted are DVT, CT scan of lungs , nuclear tests with no data.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: follow up received on 23-jun-21 with non significant information
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Palpitations
Clinical narrative: I could not breathe/shortness of breath; I had palpitations; still have trouble going up the stairs; This spontaneous case was reported by a pharmacist and describes the occurrence of DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs). At the time of the report, DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Blood pressure increased: high (High) high. On 13-Feb-2021, Fibrin D dimer increased (Unknown-1.6): high (High) 1.6. On an unknown date, Computerised tomogram: inconclusive (Inconclusive) inconclusive. On an unknown date, Deep vein thrombosis: inconclusive (Inconclusive) inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant history was not reported .The treatment history was not provided. the lab tests conducted are DVT, CT scan of lungs , nuclear tests with no data.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: follow up received on 23-jun-21 with non significant information
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: havent been feeling myself lately; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (havent been feeling myself lately) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (havent been feeling myself lately). At the time of the report, FEELING ABNORMAL (havent been feeling myself lately) outcome was unknown.            No concomitant medications was reported.  No treatment drug details was reported.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Insomnia, Pyrexia, Vaccination site pain
Clinical narrative: fever; chills; Vaccination site pain; Difficulty sleeping; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), VACCINATION SITE PAIN (Vaccination site pain) and INSOMNIA (Difficulty sleeping) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Jun-2021, the patient experienced PYREXIA (fever), CHILLS (chills), VACCINATION SITE PAIN (Vaccination site pain) and INSOMNIA (Difficulty sleeping). At the time of the report, PYREXIA (fever), CHILLS (chills), VACCINATION SITE PAIN (Vaccination site pain) and INSOMNIA (Difficulty sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication provided by reporter. No concomitant medication provided by reporter.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Vaccination site pain
Clinical narrative: Arm mobility was restricted; My left arm was very painful at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Arm mobility was restricted) and VACCINATION SITE PAIN (My left arm was very painful at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20Ai and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Herpes simplex from 01-Jan-2021 to 02-Mar-2021. Concurrent medical conditions included Penicillin allergy, Hypothyroidism since 1983 and Essential hypertension since 2018. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 1989 to an unknown date, LIOTHYRONINE SODIUM (CYTOMEL) from 1995 to an unknown date and OLMESARTAN from 2018 to an unknown date for an unknown indication.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced MOBILITY DECREASED (Arm mobility was restricted) and VACCINATION SITE PAIN (My left arm was very painful at injection site). On 31-Jan-2021, MOBILITY DECREASED (Arm mobility was restricted) and VACCINATION SITE PAIN (My left arm was very painful at injection site) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-002194 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Eye contusion
Clinical narrative: Why would i get a black eye from my second  dose; This spontaneous case was reported by a consumer and describes the occurrence of EYE CONTUSION (Why would i get a black eye from my second  dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced EYE CONTUSION (Why would i get a black eye from my second  dose). At the time of the report, EYE CONTUSION (Why would i get a black eye from my second  dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. No treatment was reported
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Extremely tired; Headache; Sore; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extremely tired), HEADACHE (Headache) and MYALGIA (Sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extremely tired), HEADACHE (Headache) and MYALGIA (Sore). The patient was treated with NAPROXEN SODIUM (ALEVE) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, FATIGUE (Extremely tired), HEADACHE (Headache) and MYALGIA (Sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-Up received on 21-JUL-2021 and does not contain any new information.; Sender's Comments: This is an invalid case due to no identifiable patient. However, based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: today all my joints ache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (today all my joints ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (today all my joints ache).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed second vaccine window / haven't received 2nd dosage what should I do?; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed second vaccine window / haven't received 2nd dosage what should I do?) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed second vaccine window / haven't received 2nd dosage what should I do?). On 19-Jun-2021, PRODUCT DOSE OMISSION ISSUE (missed second vaccine window / haven't received 2nd dosage what should I do?) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. List of concomitant medication were not given.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: NNI
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: My son in law got his second shot yesterday and is now running a temp of 105; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (My son in law got his second shot yesterday and is now running a temp of 105) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (My son in law got his second shot yesterday and is now running a temp of 105). At the time of the report, PYREXIA (My son in law got his second shot yesterday and is now running a temp of 105) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 105 (High) High.         No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Accident, Product dose omission issue
Clinical narrative: Not Received a Second Dose (About 3 months post first shot); Ski Accident after first dose; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not Received a Second Dose (About 3 months post first shot)) and ACCIDENT (Ski Accident after first dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Accident (ski accident) since 20-Mar-2021.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced ACCIDENT (Ski Accident after first dose). On 23-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not Received a Second Dose (About 3 months post first shot)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not Received a Second Dose (About 3 months post first shot)) and ACCIDENT (Ski Accident after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication provided by reporter. No concomitant medication provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: more than 35 days from 1st vaccination; COVID-19; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (more than 35 days from 1st vaccination) and COVID-19 (COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 35 days from 1st vaccination) and COVID-19 (COVID-19). At the time of the report, PRODUCT DOSE OMISSION ISSUE (more than 35 days from 1st vaccination) and COVID-19 (COVID-19) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral coldness
Clinical narrative: tingling; cold sensation in feet; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in feet) and PERIPHERAL COLDNESS (cold sensation in feet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling in feet) and PERIPHERAL COLDNESS (cold sensation in feet). At the time of the report, PARAESTHESIA (tingling in feet) and PERIPHERAL COLDNESS (cold sensation in feet) had not resolved.            No concomitant medications reported. No treatment information was provided.   Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient received 1st dose 2Apr2021 did not receive 2nd dose because she could not get in touch with the vaccination site; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose 2Apr2021 did not receive 2nd dose because she could not get in touch with the vaccination site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose 2Apr2021 did not receive 2nd dose because she could not get in touch with the vaccination site). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient received 1st dose 2Apr2021 did not receive 2nd dose because she could not get in touch with the vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: 11 patients received doses of temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (11 patients received doses of temperature excursion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (11 patients received doses of temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (11 patients received doses of temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment information was reported   This case was linked to US-MODERNATX (E2B Linked Report). This case was linked to MOD-2021-232457, MOD-2021-232457 (Patient Link).; Sender's Comments:  US-MODERNATX:irms
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Muscle spasms, Myalgia
Clinical narrative: muscle pain; sharp thigh cramping; right upper shoulder blade; headaches; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (muscle pain), MUSCLE SPASMS (sharp thigh cramping), ARTHRALGIA (right upper shoulder blade) and HEADACHE (headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain), MUSCLE SPASMS (sharp thigh cramping), ARTHRALGIA (right upper shoulder blade) and HEADACHE (headaches). At the time of the report, MYALGIA (muscle pain), MUSCLE SPASMS (sharp thigh cramping), ARTHRALGIA (right upper shoulder blade) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash all over my face and neck; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over my face and neck) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced RASH (rash all over my face and neck). At the time of the report, RASH (rash all over my face and neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication given.  No treatment information provided.